Monday, June 2, 2003 - including Plenary Sessions

ASCO 2003 ASCO 2003
OncoLink Editor-in-Chief Dr. James Metz and OncoLink Managing Editor Maggie Hampshire

A Phase III Trial comparing Gemcitabine plus Cisplatin vs. Gemcitabine alone in advanced pancreatic cancer A randomized trial of direct decompressive surgical resection in the treatment of spinal cord compression caused by metastasis Age as a continuous variable in predicting outcome for neuroblastoma patients with metastatic disease: Impact of tumor biological features Definitive results of a comparative longitudinal quality of life study using the Spitzer index in the randomized multicentric phase III trial FFCD 9102 (surgery vs. radiochemotherapy in patients with locally advanced esophageal cancer) Docetaxel and cisplatin versus M-VAC in advanced urothelial carcinoma: A multicenter, randomized, phase III study conducted by the Hellenic Cooperative Oncology Group Docetaxel, Cisplatin, 5-Fluorouracil compare to Cisplatin and 5-fluorouracil for chemotherapy-naive patients with metastatic or locally recurrent, unresectable gastric carcinoma (MGC): Interim results of a randomized phase III trial (V325) Emerging science: Prospective validation of gene expression profiling-based prediction of complete pathologic response to neoadjuvant paclitaxel/FAC chemotherapy in breast cancer Gemcitabine vs. GEMOX (gemcitabine + oxaliplatin) in non-resectable pancreatic adenocarcinoma: Interim results of GERCOR/GISCAD intergroup Phase III Low dose bleomycin every three weeks with cisplatin and etoposide results in excellent event free survival and survival in children and adolescents with gonadal malignant germ cell tumors (MGCT) A POG/CCG Study MRI screening for breast cancer in women with high familial and genetic risk: First results of the Dutch MRI screening study (MRISC) Perioperative chemotherapy in operable gastric and lower oesophageal cancer: A randomized, controlled trial (the MAGIC trial, ISRCTN 9379397) Randomised phase 3 trial of dose dense ICE chemotherapy versus standard ICE in good prognosis small cell lung cancer (SCLC) Randomized phase III trial in locally advanced squamous cell carcinoma (SCC) of the esophagus: chemoradiation with and without surgery Results from a phase II trial of conformal radiation therapy (CRT)for pediatric patients with localized ependymoma and quantification of radiation-related CNS effects Results of a randomized International Adjuvant Lung Cancer Trial (IALT): cisplatin-based chemotherapy (CT) vs no CT in 1867 patients (pts) with resected non-small cell lung cancer (NSCLC) Surgical variables impact bladder cancer outcomes: A cooperative group report Surveillance of "high-risk" women with proven or suspected familial (hereditary) breast cancer: First mid-term results of a multi-modality clinical screening trial Whole Abdominal radiotherapy versus combination doxorubicin-cisplatin chemotherapy in advanced endometrial carcinoma: A randomized phase III trial of the Gynecologic Oncology Group


Click on any of these terms for more related articles


Mushroom Medley Side Dish
by OncoLink Editorial Team
May 20, 2013

Where Are the Adults in the Room?
by Rodney Warner, JD
November 20, 2015

Related News

ASCO Issues Recommendations for Promoting Tobacco Control

Jul 30, 2013

Improved education, support for tobacco control policies, more research recommended

Preoperative Breast MRI Use Increased From 2003 to 2012

Nov 24, 2015

Eight-fold increase during 10-year period; MRI use linked to more ancillary investigations

Glucagon-Like Peptide-1 Therapy Ups Pancreatitis Risk

Sep 26, 2011

Exenatide, sitagliptin up odds ratio of pancreatitis, increase reports of pancreatic cancers